{"content":"<li class=\"n-box-item date-title\" data-end=\"1574917199\" data-start=\"1574830800\" data-txt=\"Monday, December 23, 2019\">Wednesday, November 27, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3522544\" data-ts=\"1574893958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522544-s-and-p-makes-index-moves-for-viacom-cbs-deal-wrbminus-1_7-joeplus-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P makes index moves for Viacom/CBS deal; WRB -1.7%, JOE +2.7%</a></h4><ul>    <li>The upcoming re-merger of Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>) and <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> is set to kick off <a href=\"https://us.spindices.com/documents/indexnews/announcements/20191127-1041559/1041559_BerkleyRJoe546.pdf?force_download=true\" target=\"_blank\">rippling changes to the S&amp;P indexes</a>.</li>    <li>S&amp;P says that W.R. Berkley (NYSE:<a href='https://seekingalpha.com/symbol/WRB' title='W. R. Berkley Corporation'>WRB</a>) is set to make a move up to the S&amp;P 500 to replace Viacom. <a href='https://seekingalpha.com/symbol/WRB' title='W. R. Berkley Corporation'>WRB</a> is <font color=\"red\">down 1.7%</font> after hours.</li>    <li>Taking WRB's place in the MidCap 400 is <a href='https://seekingalpha.com/symbol/RLI' title='RLI Corp.'>RLI</a>.</li>    <li>And RLI will be replaced in the SmallCap 600 by St. Joe (NYSE:<a href='https://seekingalpha.com/symbol/JOE' title='The St. Joe Company'>JOE</a>); <a href='https://seekingalpha.com/symbol/JOE' title='The St. Joe Company'>JOE</a> is <font color=\"green\">up 2.7%</font> after hours.</li>    <li>After CBS acquires Viacom, the combined company will be called ViacomCBS and trade on Nasdaq under the <a href='https://seekingalpha.com/symbol/VIAC' title='ViaCell Inc.'>VIAC</a> ticker.</li>    <li>The index moves are effective prior to the open of trading on Thursday, Dec. 5.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522544\" data-linked=\"S&amp;P makes index moves for Viacom/CBS deal; WRB -1.7%, JOE +2.7%\" data-tweet=\"$VIA $VIAB $VIAC - S&amp;P makes index moves for Viacom/CBS deal; WRB -1.7%, JOE +2.7% https://seekingalpha.com/news/3522544-s-and-p-makes-index-moves-for-viacom-cbs-deal-wrbminus-1_7-joeplus-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3522544-s-and-p-makes-index-moves-for-viacom-cbs-deal-wrbminus-1_7-joeplus-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522542\" data-ts=\"1574893215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTNT\" target=\"_blank\">QTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522542-quotientminus-13_4-terminates-ortho-clinical-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient -13.4% as it terminates Ortho-Clinical deal</a></h4><ul>   <li>Quotient Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a>) is <font color=\"red\">13.4% lower</font> postmarket after noting in an <a href=\"https://seekingalpha.com/filing/4718325\" target=\"_blank\">SEC filing</a> that it has terminated a distribution and supply agreement with Ortho-Clinical Diagnostics (a significant customer of Quotient's conventional reagent business) covering its MosaiQ Microarrays in certain markets.</li>    <li>Quotient had noted in its quarterly report that it notified Ortho of material breaches of their deal, and gave the company 60 days to cure the breaches. Ortho disagreed that it had breached its agreement.</li>    <li>So Quotient has given notice that it's terminated the deal, which will be effective on Dec. 27.</li>    <li>Ortho has since initiated arbitration and filed a federal lawsuit looking to enjoin the termination.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522542\" data-linked=\"Quotient -13.4% as it terminates Ortho-Clinical deal\" data-tweet=\"$QTNT - Quotient -13.4% as it terminates Ortho-Clinical deal https://seekingalpha.com/news/3522542-quotientminus-13_4-terminates-ortho-clinical-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3522542-quotientminus-13_4-terminates-ortho-clinical-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522534\" data-ts=\"1574891043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522534-senseonicsminus-3_7-on-filing-to-offer-up-to-50m-in-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senseonics -3.7% on filing to offer up to $50M in shares</a></h4><ul>   <li>Senseonics Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings, Inc.'>SENS</a>) is <font color=\"red\">3.7% lower</font> postmarket after disclosing an open market sales agreement for <a href=\"https://seekingalpha.com/filing/4718087\" target=\"_blank\">up to $50M in shares</a>.</li>    <li>That agreement is with Jefferies; it doesn't mean that a sale has begun or will begin, but the company may offer shares from time to time under the deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522534\" data-linked=\"Senseonics -3.7% on filing to offer up to $50M in shares\" data-tweet=\"$SENS - Senseonics -3.7% on filing to offer up to $50M in shares https://seekingalpha.com/news/3522534-senseonicsminus-3_7-on-filing-to-offer-up-to-50m-in-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3522534-senseonicsminus-3_7-on-filing-to-offer-up-to-50m-in-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522529\" data-ts=\"1574889584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHRS\" target=\"_blank\">CHRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522529-coherus-jumps-on-report-canceled-piper-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coherus jumps on report it&#39;s canceled Piper talk</a></h4><ul>    <li>Coherus BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences, Inc.'>CHRS</a>) jumped into today's pre-holiday close after Mizuho's Salim Syed says he's heard the company canceled from next week's Piper Jaffray conference.</li>    <li>A brief spike pushed the company to a <font color=\"green\">5.9% gain</font> in the waning minutes before it settled for a <font color=\"green\">3.4% gain</font> on the day.</li>    <li>The company was set to present at Piper's healthcare event in New York Tuesday. (h/t Bloomberg)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3522529\" data-linked=\"Coherus jumps on report it&#39;s canceled Piper talk\" data-tweet=\"$CHRS - Coherus jumps on report it&#39;s canceled Piper talk https://seekingalpha.com/news/3522529-coherus-jumps-on-report-canceled-piper-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3522529-coherus-jumps-on-report-canceled-piper-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522526\" data-ts=\"1574888292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522526-axon-gets-two-notch-downgrade-raymond-james-after-recent-run-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axon gets two-notch downgrade at Raymond James after recent run-up</a></h4><ul><li>Axon (<a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a> <font color=\"red\">-1.9%</font>) slides from YTD highs after Raymond James <a href=\"https://thefly.com/thestreet/realmoney/index.php/AAXNid2999879/AAXN-Raymond-James-double-downgrades-Axon-after-unsustainable-move-higher\" target=\"_blank\">double downgrades</a> shares to Market Perform from Strong Buy, saying the stock's \"unsustainable energetic move higher\" this month cannot be reconciled with fundamentals of the business.</li><li>Ray Jay analyst Brian Gesuale  notes the stock has rallied ~50% in  the last three weeks, some of which can be chalked up to short covering and a  technical breakout.</li><li>But Gesuale says it is hard to know when those  catalysts will run their course and the stock's positive momentum will  reverse.</li><li>AAXN's average <a href=\"https://seekingalpha.com/symbol/AAXN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> and <a href=\"https://seekingalpha.com/symbol/AAXN/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> both are Bullish, while its <a href=\"https://seekingalpha.com/symbol/AAXN/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522526\" data-linked=\"Axon gets two-notch downgrade at Raymond James after recent run-up\" data-tweet=\"$AAXN - Axon gets two-notch downgrade at Raymond James after recent run-up https://seekingalpha.com/news/3522526-axon-gets-two-notch-downgrade-raymond-james-after-recent-run-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3522526-axon-gets-two-notch-downgrade-raymond-james-after-recent-run-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522524\" data-ts=\"1574887634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522524-deere-in-dumps-investors-adjust-for-gloomy-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere in the dumps as investors adjust for gloomy outlook</a></h4><ul><li>Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='red'>-4.2%</font>) bumps along at the bottom of today's S&amp;P 500 listings after <a href=\"https://seekingalpha.com/news/3522338-deere-minus-4_5-percent-2020-profit-warning\" target=\"_blank\">forecasting lower sales and profits</a> next year, expecting U.S. farmers will remain reluctant to buy machinery after a disappointing harvest.</li><li>DE now sees FY 2020 net income of $2.7B-$3.1B, lower than this year and well below the analyst consensus estimate of $3.46B.</li><li>Analysts had been forecasting a slight uptick in sales next year, but the company expects a 5%\u201010% decline in full-year equipment sales for its Agriculture &amp; Turf segment, while sales in the Construction &amp; Forestry segment look even worse with a 10%-15% drop.</li><li>One reason DE's <a href=\"https://www.bnnbloomberg.ca/deere-s-dour-outlook-tests-faith-in-manufacturing-rebound-1.1354396\" target=\"_blank\">lackluster guidance has slammed the stock</a> is that the forecast was not accompanied by much detail on restructuring that the company had said would be forthcoming, writes Bloomberg's Brooke Sutherland.</li><li>In the broader market, DE expects demand for agricultural equipment to drop 5% in the U.S. and Canada, while the European, South American and Asian markets remain flat - not as severe as the company's outlook for its own business, which Jefferies analyst Stephen Volkmann says likely reflects an expectation that dealers are still sitting on too much inventory and will work through that before placing new orders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522524\" data-linked=\"Deere in the dumps as investors adjust for gloomy outlook\" data-tweet=\"$DE - Deere in the dumps as investors adjust for gloomy outlook https://seekingalpha.com/news/3522524-deere-in-dumps-investors-adjust-for-gloomy-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3522524-deere-in-dumps-investors-adjust-for-gloomy-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522521\" data-ts=\"1574885746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTGN\" target=\"_blank\">NTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522521-neon-therapeutics-downgraded-wainwright-on-strategy-shift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neon Therapeutics downgraded at Wainwright on strategy shift</a></h4><ul><li>Neon Therapeutics (<a href='https://seekingalpha.com/symbol/NTGN' title='Neon Therapeutics, Inc.'>NTGN</a> <font color='red'>-7.1%</font>) extends <a href=\"https://seekingalpha.com/news/3522189-neon-therapeutics-hits-low-morgan-stanley-throws-towel\" target=\"_blank\">yesterday's sharp losses</a> after H.C. Wainwright piles on with a <a href=\"https://thefly.com/thestreet/realmoney/index.php/NTGNid2999855/NTGN-Neon-Therapeutics-downgraded-to-Neutral-from-Buy-at-HC-Wainwright\" target=\"_blank\">fresh downgrade</a> to Neutral from Buy, citing the  company's restructuring and strategic shift.</li><li>Neon announced last week plans to cut its workforce by 24% and cease  funding additional research and development for its NEO-PV-01 and NEO-SV-01 cancer vaccine programs.</li><li>Morgan Stanley yesterday <a href=\"https://thefly.com/thestreet/realmoney/index.php/NTGNid2999646/NTGN-Morgan-Stanley-double-downgrades-Neon-Therapeutics-to-Underweight\" target=\"_blank\">double downgraded</a> shares to  Underweight with a $1 price target, cut from $13, noting that NEO-PV-01 had been the company's lead product  candidate and the newly prioritized  neoantigen-targeted T-cell therapy platform is too early in development  to value, given that Phase 1 data is not expected until 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522521\" data-linked=\"Neon Therapeutics downgraded at Wainwright on strategy shift\" data-tweet=\"$NTGN - Neon Therapeutics downgraded at Wainwright on strategy shift https://seekingalpha.com/news/3522521-neon-therapeutics-downgraded-wainwright-on-strategy-shift?source=tweet\" data-url=\"https://seekingalpha.com/news/3522521-neon-therapeutics-downgraded-wainwright-on-strategy-shift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522520\" data-ts=\"1574884853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522520-internet-gold-golden-lines-and-avx-among-energy-materials-gainers-zedge-and-technical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Internet Gold - Golden Lines and AVX among Energy/Materials gainers; Zedge and Technical Communications among losers</a></h4><ul><li><b>Gainers: </b>Internet Gold - Golden Lines (NASDAQ:<a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold - Golden Lines Ltd.'>IGLD</a>) <font color=\"green\">+40%</font>. AVX (NYSE:<a href='https://seekingalpha.com/symbol/AVX' title='AVX Corporation'>AVX</a>) <font color=\"green\">+37%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"green\">+21%</font>. CooTek (NYSE:<a href='https://seekingalpha.com/symbol/CTK' title='CooTek &#40;Cayman&#41; Inc.'>CTK</a>) <font color=\"green\">+14%</font>. SCWorx (NASDAQ:<a href='https://seekingalpha.com/symbol/WORX' title='SCWorx Corp.'>WORX</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Zedge (NYSEMKT:<a href='https://seekingalpha.com/symbol/ZDGE' title='Zedge, Inc.'>ZDGE</a>) <font color=\"red\">-14%</font>. Technical Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corporation'>TCCO</a>) <font color=\"red\">-11%</font>. Daktronics (NASDAQ:<a href='https://seekingalpha.com/symbol/DAKT' title='Daktronics, Inc.'>DAKT</a>) <font color=\"red\">-10%</font>. TechTarget (NASDAQ:<a href='https://seekingalpha.com/symbol/TTGT' title='TechTarget, Inc.'>TTGT</a>) <font color=\"red\">-9%</font>. One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522520\" data-linked=\"Internet Gold - Golden Lines and AVX among Energy/Materials gainers; Zedge and Technical Communications among losers\" data-tweet=\"$IGLD $AVX $GTT - Internet Gold - Golden Lines and AVX among Energy/Materials gainers; Zedge and Technical Communications among losers https://seekingalpha.com/news/3522520-internet-gold-golden-lines-and-avx-among-energy-materials-gainers-zedge-and-technical?source=tweet\" data-url=\"https://seekingalpha.com/news/3522520-internet-gold-golden-lines-and-avx-among-energy-materials-gainers-zedge-and-technical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522515\" data-ts=\"1574883125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522515-softbank-joining-work-on-fast-maritime-network\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoftBank joining work on fast maritime network</a></h4><ul>   <li>SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color=\"green\">+1.6%</font>) is taking part in a joint venture to build a <a href=\"https://asia.nikkei.com/Business/Telecommunication/SoftBank-joins-quest-for-remote-piloted-ships\" target=\"_blank\">fast maritime network</a> paving the way to remote-controlled ships, Nikkei reports.</li>    <li>The project is led by e5 Lab, whose investors include Mitsui OSK (<a href='https://seekingalpha.com/symbol/MSLOY' title='Mitsui O.S.K. Lines, Ltd.'>OTCPK:MSLOY</a>), Asahi Tanker and Mitsubishi. The service will use a satellite constellation from OneWeb, about half-owned by SoftBank.</li>    <li>And OneWeb expects the network to deliver speeds of 400 Mbps, about 100 times faster than current maritime networks. Remote control of ships could halve crew requirements for many ships, in an industry facing worker shortages.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522515\" data-linked=\"SoftBank joining work on fast maritime network\" data-tweet=\"$SFTBY $MSLOY $SFTBY - SoftBank joining work on fast maritime network https://seekingalpha.com/news/3522515-softbank-joining-work-on-fast-maritime-network?source=tweet\" data-url=\"https://seekingalpha.com/news/3522515-softbank-joining-work-on-fast-maritime-network\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522509\" data-ts=\"1574881425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522509-ossen-innovation-and-chaparral-energy-among-energy-materials-gainers-fts-international-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ossen Innovation and Chaparral Energy among Energy/Materials gainers; FTS International and PEDEVCO among losers</a></h4><ul><li><b>Gainers: </b>Ossen Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a>) <font color=\"green\">+9%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+8%</font>. Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"green\">+6%</font>. Helmerich &amp; Payne (NYSE:<a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne, Inc.'>HP</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>FTS International (NYSE:<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a>) <font color=\"red\">-7%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-7%</font>. SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-7%</font>. Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-5%</font>. Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522509\" data-linked=\"Ossen Innovation and Chaparral Energy among Energy/Materials gainers; FTS International and PEDEVCO among losers\" data-tweet=\"$OSN $CHAP $SDRL - Ossen Innovation and Chaparral Energy among Energy/Materials gainers; FTS International and PEDEVCO among losers https://seekingalpha.com/news/3522509-ossen-innovation-and-chaparral-energy-among-energy-materials-gainers-fts-international-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3522509-ossen-innovation-and-chaparral-energy-among-energy-materials-gainers-fts-international-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522506\" data-ts=\"1574881101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522506-zillow-slides-after-pending-home-sales-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow slides after pending home sales fall</a></h4><ul><li>Zillow (<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a> <font color='red'>-2.5%</font>)(<a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a> <font color='red'>-2.4%</font>) and Redfin (<a href='https://seekingalpha.com/symbol/RDFN' title='Redfin Corporation'>RDFN</a> <font color='red'>-0.1%</font>) shares drop after the National Association of Realtors <a href=\"https://www.cnbc.com/2019/11/27/pending-home-sales-fall-1point7percent-in-october-as-housing-shortage-worsens.html\" target=\"_blank\">reported</a> that pending home sales fell 1.7% on the month in October.</li><li>Sales were up 4.4% annually, which is likely due to the low mortgage rates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522506\" data-linked=\"Zillow slides after pending home sales fall\" data-tweet=\"$Z $ZG $RDFN - Zillow slides after pending home sales fall https://seekingalpha.com/news/3522506-zillow-slides-after-pending-home-sales-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3522506-zillow-slides-after-pending-home-sales-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522505\" data-ts=\"1574880974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCMI\" target=\"_blank\">NCMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522505-national-cinemedia-adds-director-from-standard-general\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National CineMedia adds director from Standard General</a></h4><ul>   <li>National CineMedia (<a href=\"http://seekingalpha.com/symbol/NCMI\" target=\"_blank\">NCMI</a> <font color=\"green\">+3.9%</font>) has <a href=\"https://seekingalpha.com/filing/4716129\" target=\"_blank\">elected David Glazek</a> to a board seat as a designee of Standard General.</li>    <li>That comes under an agreement with Standard General from June 2018.</li>    <li>Glazek's appointment comes in connection with the resignation of Andrew Glaze, Standard General's previous board designee.</li>    <li>Glazek (an independent director) joined Standard General in 2008; he's currently chairman of Turning Point Brands.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522505\" data-linked=\"National CineMedia adds director from Standard General\" data-tweet=\"$NCMI - National CineMedia adds director from Standard General https://seekingalpha.com/news/3522505-national-cinemedia-adds-director-from-standard-general?source=tweet\" data-url=\"https://seekingalpha.com/news/3522505-national-cinemedia-adds-director-from-standard-general\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522501\" data-ts=\"1574880546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522501-dell-hp-call-out-intels-cpu-constraints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dell, HP call out Intel&#39;s CPU constraints</a></h4><ul><li>Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color=\"red\">-1%</font>) are seeing red today after <a href=\"https://seekingalpha.com/article/4309352-dell-technologies-inc-dell-q3-2020-results-earnings-call-transcript\" target=\"_blank\">Dell</a> (<a href='https://seekingalpha.com/symbol/DELL' title='Dell Technologies Inc.'>DELL</a> <font color=\"red\">-6%</font>) and <a href=\"https://seekingalpha.com/article/4309348-hp-inc-hpq-ceo-enrique-lores-q4-2019-results-earnings-call-transcript\" target=\"_blank\">HP</a> (<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a> <font color='red'>-1%</font>) both cited the company's CPU supply constraints for weak PC sales.</li><li>Dell lowered its FY20 revenue guidance to $91.5-92.2B compared to the $93.54B consensus.</li><li>HP didn't provide guidance but said the Intel impact could hit HPQ's revenue.</li><li>Rival AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color=\"green\">+0.4%</font>) is gaining on the news.</li><li>Related: Last week, Intel <a href=\"https://seekingalpha.com/news/3521185-intel-apologizes-cpu-shipment-delays\" target=\"_blank\">apologized </a>to customers for the continuing CPU product delays.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522501\" data-linked=\"Dell, HP call out Intel&#39;s CPU constraints\" data-tweet=\"$INTC $DELL $HPQ - Dell, HP call out Intel&#39;s CPU constraints https://seekingalpha.com/news/3522501-dell-hp-call-out-intels-cpu-constraints?source=tweet\" data-url=\"https://seekingalpha.com/news/3522501-dell-hp-call-out-intels-cpu-constraints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>119&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522551\" data-ts=\"1574880519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRK\" target=\"_blank\">CRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522551-contrarian-jones-seeking-gas-assets-for-comstock-resources\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Contrarian Jones seeking more gas assets for Comstock Resources</a></h4><ul><li>Comstock Resources (<a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources, Inc.'>CRK</a> <font color='green'>+2%</font>) majority owner Jerry Jones says he is <a href=\"https://www.bnnbloomberg.ca/cowboys-owner-jerry-jones-says-he-s-hunting-for-more-gas-assets-1.1354299\" target=\"_blank\">hunting for even more acreage</a> at Louisiana's out-of-favor Haynesville shale gas play, calling it the best bet for low-cost hydrocarbons.</li><li>\"My immediate plan is to continue to aggregate long-term reserves to have the most efficient source of natural gas,\" Jones tells Bloomberg.</li><li>Haynesville values are down due to a  nationwide natural gas glut, and the 53 rigs  drilling wells there has dropped by more than two-thirds from early 2011.</li><li>While rival gas drillers such as Chesapeake Energy have sought to pump more  oil, CRK has pursued a contrarian course, shifting deeper into gas  by reducing crude to just 9% of production in 2018 from 39% in 2014.</li><li>Despite his disappointment with the Dallas Cowboys football season so far, he says \"I have no plans  to sell the Cowboys and I have no plans to sell Comstock.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3522551\" data-linked=\"Contrarian Jones seeking more gas assets for Comstock Resources\" data-tweet=\"$CRK - Contrarian Jones seeking more gas assets for Comstock Resources https://seekingalpha.com/news/3522551-contrarian-jones-seeking-gas-assets-for-comstock-resources?source=tweet\" data-url=\"https://seekingalpha.com/news/3522551-contrarian-jones-seeking-gas-assets-for-comstock-resources\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522466\" data-ts=\"1574878318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VG\" target=\"_blank\">VG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522466-vonageplus-2_7-jpmorgan-sees-25-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vonage +2.7% as JPMorgan sees 25% upside</a></h4><ul>   <li>Vonage Holdings (NYSE:<a href='https://seekingalpha.com/symbol/VG' title='Vonage Holdings Corp.'>VG</a>) is <font color=\"green\">up 2.7%</font> after an initiation at Neutral by JPMorgan, but with a healthy price target.</li>    <li>The firm's Sterling Auty set its target at $9.50, implying 25% upside from yesterday's close despite the Neutral stance.</li>    <li>That's still a below-average price target, with the rest of the sell side <a href=\"https://seekingalpha.com/symbol/VG/ratings/sell-side-ratings\" target=\"_blank\">Bullish on the shares</a>. Vonage meanwhile has a <a href=\"https://seekingalpha.com/symbol/VG/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Very Bearish</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3522466\" data-linked=\"Vonage +2.7% as JPMorgan sees 25% upside\" data-tweet=\"$VG - Vonage +2.7% as JPMorgan sees 25% upside https://seekingalpha.com/news/3522466-vonageplus-2_7-jpmorgan-sees-25-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3522466-vonageplus-2_7-jpmorgan-sees-25-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522465\" data-ts=\"1574878135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522465-360-finance-leads-financial-gainers-weidai-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">360 Finance leads financial gainers; Weidai the only loser</a></h4><ul><li><b>Gainers:</b> 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"green\">+12%</font>. Banco BBVA Argentina (NYSE:<a href='https://seekingalpha.com/symbol/BBAR' title='Banco BBVA Argentina S.A.'>BBAR</a>) <font color=\"green\">+10%</font>. Sculptor Capital Management (NYSE:<a href='https://seekingalpha.com/symbol/SCU' title='Sculptor Capital Management, Inc.'>SCU</a>) <font color=\"green\">+9%</font>. FinVolution Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='FinVolution Group'>PPDF</a>) <font color=\"green\">+9%</font>. Grupo Financiero Galicia (NASDAQ:<a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:</b> Weidai (NYSE:<a href='https://seekingalpha.com/symbol/WEI' title='Weidai Ltd.'>WEI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522465\" data-linked=\"360 Finance leads financial gainers; Weidai the only loser\" data-tweet=\"$QFIN $BBAR $SCU - 360 Finance leads financial gainers; Weidai the only loser https://seekingalpha.com/news/3522465-360-finance-leads-financial-gainers-weidai-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3522465-360-finance-leads-financial-gainers-weidai-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522463\" data-ts=\"1574877571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522463-broadwind-energy-only-industrial-gainer-capstone-turbine-and-deere-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadwind Energy only industrial gainer; Capstone Turbine and Deere in losers</a></h4><ul><li><b>Gainers: </b>Broadwind Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/BWEN' title='Broadwind Energy, Inc.'>BWEN</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) <font color=\"red\">-10%</font>. Deere &amp; Company (NYSE:<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a>) <font color=\"red\">-5%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3522463\" data-linked=\"Broadwind Energy only industrial gainer; Capstone Turbine and Deere in losers\" data-tweet=\"$BWEN $CPST $DE - Broadwind Energy only industrial gainer; Capstone Turbine and Deere in losers https://seekingalpha.com/news/3522463-broadwind-energy-only-industrial-gainer-capstone-turbine-and-deere-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522463-broadwind-energy-only-industrial-gainer-capstone-turbine-and-deere-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522461\" data-ts=\"1574877486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522461-onconova-cut-maxim-seeing-another-capital-raise-likely\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova cut at Maxim, seeing another capital raise likely</a></h4><ul><li>Onconova Therapeutics (<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a> <font color=\"green\">+36.5%</font>) is <a href=\"https://www.streetinsider.com/Downgrades/Maxim+Group+Downgrades+Onconova+Therapeutics+%28ONTX%29+to+Hold/16182327.html\" target=\"_blank\">downgraded</a> to Hold from Buy at Maxim Group, which also removes its $2 price target, citing \"a combination of the dilution associated with the <a href=\"https://seekingalpha.com/news/3521271-onconova-therapeutics-slides-share-offering\" target=\"_blank\">recent equity  offering</a>, the distressed valuation of the company, cash runway and Nasdaq compliance status.\"</li><li>Maxim analyst Jason McCarthy questions whether the public offering will be enough to fund it until it can get data from its Inspire Phase 3 trial.</li><li>Shares are surging today but are still ~60% below the $0.40 closing price a week ago.</li><li>ONTX's average <a href=\"https://seekingalpha.com/symbol/ONTX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Bullish, but its <a href=\"https://seekingalpha.com/symbol/ONTX/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Very Bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522461\" data-linked=\"Onconova cut at Maxim, seeing another capital raise likely\" data-tweet=\"$ONTX - Onconova cut at Maxim, seeing another capital raise likely https://seekingalpha.com/news/3522461-onconova-cut-maxim-seeing-another-capital-raise-likely?source=tweet\" data-url=\"https://seekingalpha.com/news/3522461-onconova-cut-maxim-seeing-another-capital-raise-likely\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522456\" data-ts=\"1574876525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522456-abeo-hepa-evh-and-kzia-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ABEO, HEPA, EVH and KZIA among midday movers</a></h4><ul><li><strong>Gainers: </strong>Paringa Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/PNRL' title='Paringa Resources Limited'>PNRL</a>) <font color=\"green\">+250%</font>.</li><li>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+137%</font>.</li><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+42%</font>.</li><li>AVX (NYSE:<a href='https://seekingalpha.com/symbol/AVX' title='AVX Corporation'>AVX</a>) <font color=\"green\">+36%</font>.</li><li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"green\">+22%</font>.</li><li>Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"green\">+17%</font>.</li><li>GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"green\">+16%</font>.</li><li>Myovant Sciences (NYSE:<a href='https://seekingalpha.com/symbol/MYOV' title='Myovant Sciences Ltd.'>MYOV</a>) <font color=\"green\">+15%</font>.</li><li>360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"green\">+14%</font>.</li><li>Protagonist Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a>) <font color=\"green\">+13%</font>.</li><li><strong>Losers: </strong>Evolent Health (NYSE:<a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health, Inc.'>EVH</a>) <font color=\"red\">-33%</font>.</li><li>Central Garden &amp; Pet (NASDAQ:<a href='https://seekingalpha.com/symbol/CENT' title='Central Garden & Pet Company'>CENT</a>) <font color=\"red\">-20%</font>.</li><li>Benitec Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec Biopharma Limited'>BNTC</a>) <font color=\"red\">-17%</font>.</li><li>Aravive (NASDAQ:<a href='https://seekingalpha.com/symbol/ARAV' title='Aravive, Inc.'>ARAV</a>) <font color=\"red\">-15%</font>.</li><li>NantHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/NH' title='NantHealth, Inc.'>NH</a>) <font color=\"red\">-13%</font>.</li><li>Verrica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRCA' title='Verrica Pharmaceuticals Inc.'>VRCA</a>) <font color=\"red\">-13%</font>.</li><li>Kazia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KZIA' title='Kazia Therapeutics Limited'>KZIA</a>) <font color=\"red\">-12%</font>.</li><li>scPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a>) <font color=\"red\">-12%</font>.</li><li>Enochian Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ENOB' title='Enochian Biosciences Inc.'>ENOB</a>) <font color=\"red\">-12%</font>.</li><li>Zedge (NYSEMKT:<a href='https://seekingalpha.com/symbol/ZDGE' title='Zedge, Inc.'>ZDGE</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522456\" data-linked=\"ABEO, HEPA, EVH and KZIA among midday movers\" data-tweet=\"$PNRL $ASLN $HEPA - ABEO, HEPA, EVH and KZIA among midday movers https://seekingalpha.com/news/3522456-abeo-hepa-evh-and-kzia-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522456-abeo-hepa-evh-and-kzia-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522449\" data-ts=\"1574874948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522449-vodafoneplus-1_6-after-win-in-kabel-deutschland-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone +1.6% after win in Kabel Deutschland case</a></h4><ul>   <li>Vodafone (NASDAQ:<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>) is <font color=\"green\">1.6% higher</font> in U.S. trading after it prevailed in a long-running suit over a payout for Kabel Deutschland shareholders.</li>    <li>Activist Elliott Management had alleged that Vodafone had underpaid for the German cableco.</li>    <li>But the court ruled that the payout would be unchanged at \u20ac84.53/share and 3.77% interest per annum..</li>    <li>The stock's interim dividend ex-dividend date is tomorrow, with a record date of Friday. That dividend will pay out in February.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522449\" data-linked=\"Vodafone +1.6% after win in Kabel Deutschland case\" data-tweet=\"$VOD - Vodafone +1.6% after win in Kabel Deutschland case https://seekingalpha.com/news/3522449-vodafoneplus-1_6-after-win-in-kabel-deutschland-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3522449-vodafoneplus-1_6-after-win-in-kabel-deutschland-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522447\" data-ts=\"1574874547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMRN\" target=\"_blank\">BMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522447-biomarin-upgraded-barclays-on-optimism-for-achondroplasia-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioMarin upgraded at Barclays on optimism for achondroplasia trial</a></h4><ul><li>BioMarin Pharma (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='green'>+2.5%</font>) gets a boost as Barclays <a href=\"https://thefly.com/thestreet/realmoney/index.php/BMRNid2999902/BMRN-Barclays-upgrades-BioMarin-to-Overweight-ahead-of-achondroplasia-data\" target=\"_blank\">upgrades</a> shares to Overweight from Equal Weight with a $98 price target, raised from $86, as analyst Gena Wang sees a favorable risk/reward into the Phase 3 data readout for vosoritide, which she expects will be positive.</li><li><b> </b>Vosoritide's Phase 3 trial for treating achondroplasia is \"well powered  to allow for statistical significance,\" Wang writes, adding the shares also reflect little value for BMRN's ValRox hemophilia A gene  therapy.</li><li>BMRN's average <a href=\"https://seekingalpha.com/symbol/BMRN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a>, <a href=\"https://seekingalpha.com/symbol/BMRN/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> and <a href=\"https://seekingalpha.com/symbol/BMRN/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are all Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522447\" data-linked=\"BioMarin upgraded at Barclays on optimism for achondroplasia trial\" data-tweet=\"$BMRN - BioMarin upgraded at Barclays on optimism for achondroplasia trial https://seekingalpha.com/news/3522447-biomarin-upgraded-barclays-on-optimism-for-achondroplasia-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3522447-biomarin-upgraded-barclays-on-optimism-for-achondroplasia-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522446\" data-ts=\"1574874124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522446-eastman-kodak-only-consumer-gainers-central-garden-pet-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eastman Kodak only consumer gainers; Central Garden &amp; Pet leads losers</a></h4><ul><li><b>Gainers: </b>Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Company'>KODK</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Central Garden &amp; Pet (NASDAQ:<a href='https://seekingalpha.com/symbol/CENT' title='Central Garden & Pet Company'>CENT</a>) <font color=\"red\">-20%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522446\" data-linked=\"Eastman Kodak only consumer gainers; Central Garden &amp; Pet leads losers\" data-tweet=\"$KODK $CENT $FFHL - Eastman Kodak only consumer gainers; Central Garden &amp; Pet leads losers https://seekingalpha.com/news/3522446-eastman-kodak-only-consumer-gainers-central-garden-pet-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522446-eastman-kodak-only-consumer-gainers-central-garden-pet-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522442\" data-ts=\"1574873635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522442-seelosplus-6-on-dosing-in-phase-i-ketamine-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seelos +6% on dosing in Phase I ketamine trial</a></h4><ul><li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <a href=\"https://seekingalpha.com/pr/17712737-seelos-therapeutics-announces-dosing-phase-pk-pd-study-intranasal-racemic-ketamine-slsminus\" target=\"_blank\">announces</a> the dosing of the first patients in its Phase I Pharmacokinetic and Pharmacodynamic profile study, SLS-002-102.</li><li>The two-part, randomized, double-blind, placebo-controlled, parallel and crossover study of intranasal and intravenous ketamine plans to enroll 62 healthy volunteers.</li><li>Preliminary data from the study is expected in Q1.</li><li>SEEL shares are <font color=\"green\">up 6%</font> to $0.86.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522442\" data-linked=\"Seelos +6% on dosing in Phase I ketamine trial\" data-tweet=\"$SEEL - Seelos +6% on dosing in Phase I ketamine trial https://seekingalpha.com/news/3522442-seelosplus-6-on-dosing-in-phase-i-ketamine-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3522442-seelosplus-6-on-dosing-in-phase-i-ketamine-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522429\" data-ts=\"1574870536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522429-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+150%</font>. Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"green\">+17%</font>. Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"green\">+15%</font>. Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy, Inc.'>DPLO</a>) <font color=\"green\">+14%</font>. Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Benitec Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec Biopharma Limited'>BNTC</a>) <font color=\"red\">-17%</font>. Aravive (NASDAQ:<a href='https://seekingalpha.com/symbol/ARAV' title='Aravive, Inc.'>ARAV</a>) <font color=\"red\">-15%</font>. Kazia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KZIA' title='Kazia Therapeutics Limited'>KZIA</a>) <font color=\"red\">-13%</font>. Verrica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRCA' title='Verrica Pharmaceuticals Inc.'>VRCA</a>) <font color=\"red\">-10%</font>. Enochian Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ENOB' title='Enochian Biosciences Inc.'>ENOB</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522429\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$ASLN $ZSAN $ABEO - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3522429-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522429-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522426\" data-ts=\"1574870256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522426-clovis-oncology-continues-to-squeeze-higher-amid-m-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis Oncology continues to squeeze higher amid M&amp;A hopes</a></h4><ul><li>Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a> <font color=\"green\">+13.6%</font>) is en route to its fifth straight big gain amid ongoing <a href=\"https://www.fool.com/investing/2019/11/25/the-return-of-ma-activity-is-lifting-these-biotech.aspx\" target=\"_blank\">M&amp;A chatter</a>; shares have more than quadrupled since closing at $3.00 on Oct. 25.</li><li>CLVS has tumbled from more than $90 in mid-2017, but according to Motley Fool's Maxx Chatsko, the thinking is that the further the company's valuation sinks, the more attractive it may become to a potential buyer.</li><li>BioSci Capital Partners, writing on Seeking Alpha, <a href=\"https://seekingalpha.com/article/4306015-clovis-market-valuation-still-far-intrinsic-value\" target=\"_blank\">points to fundamental developments</a>, noting the company substantially reduced its high cash burn rate this quarter and Rubraca generated robust data for castration-resistant prostate cancer with an associated BRCA1/2 mutation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522426\" data-linked=\"Clovis Oncology continues to squeeze higher amid M&amp;A hopes\" data-tweet=\"$CLVS - Clovis Oncology continues to squeeze higher amid M&amp;A hopes https://seekingalpha.com/news/3522426-clovis-oncology-continues-to-squeeze-higher-amid-m-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3522426-clovis-oncology-continues-to-squeeze-higher-amid-m-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522424\" data-ts=\"1574869816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSHB\" target=\"_blank\">KSHB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522424-kushco-up-nearly-10-on-positive-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KushCo up nearly 10% on positive coverage</a></h4><ul><li>The roughed-up pot name finds a fan in Jefferies' Owen Bennett, who starts coverage with a Buy rating and $3.50 price target - or a <font color=\"green\">more than doubling</font> from yesterday's close.</li><li>KushCo (<a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a> <font color=\"green\">+9.7%</font>) has one of the industry's cheapest valuations, says Bennett, but he expects multiple headwinds to soon abate.</li><li>The <a href=\"https://seekingalpha.com/symbol/KSHB/ratings/sell-side-ratings\" target=\"_blank\">Sell-Side in general is quite bullish</a> on KushCo - of nine folks covering there's not one bearish, or even neutral rating.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522424\" data-linked=\"KushCo up nearly 10% on positive coverage\" data-tweet=\"$KSHB - KushCo up nearly 10% on positive coverage https://seekingalpha.com/news/3522424-kushco-up-nearly-10-on-positive-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3522424-kushco-up-nearly-10-on-positive-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522421\" data-ts=\"1574869209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVH\" target=\"_blank\">EVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522421-evolent-health-plunges-after-kentucky-medicaid-contract-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evolent Health plunges after Kentucky Medicaid contract news</a></h4><ul><li>Evolent Health (<a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health, Inc.'>EVH</a> <font color=\"red\">-33.6%</font>) resumes trading after a circuit breaker halt following news that Passport Health, which the company plans to buy, <a href=\"https://www.courier-journal.com/story/news/politics/elections/kentucky/2019/11/27/kentucky-awards-contracts-manage-billions-medicaid-business-cuts-out-louisville-based-passport/4252132002/\" target=\"_blank\">lost out on a Kentucky Medicaid contract</a>.</li><li>The state has notified five other health insurance companies that they will be awarded contracts to manage $8B/year in Kentucky's managed Medicaid business, the <em>Louisville Courier Journal</em> reports, effectively cutting Passport out of work it has maintained for more than 20 years.</li><li>The loss could put Passport out of business, according to the report, because its main revenue comes from managing health care for Kentucky Medicaid enrollees, a population it was founded to serve in 1997 as a non-profit.</li><li>Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"green\">+1.1%</font>), which previously held a state contract for Medicaid managed care, also was an unsuccessful bidder but the company is much larger and more diversified than Passport.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522421\" data-linked=\"Evolent Health plunges after Kentucky Medicaid contract news\" data-tweet=\"$EVH $ANTM - Evolent Health plunges after Kentucky Medicaid contract news https://seekingalpha.com/news/3522421-evolent-health-plunges-after-kentucky-medicaid-contract-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3522421-evolent-health-plunges-after-kentucky-medicaid-contract-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522417\" data-ts=\"1574867727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAKT\" target=\"_blank\">DAKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522417-daktronics-slides-9-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daktronics slides 9% post Q2 results</a></h4><ul><li>Daktronics (<a href='https://seekingalpha.com/symbol/DAKT' title='Daktronics, Inc.'>DAKT</a> <font color=\"red\">-9.8%</font>) reported Q2 sales of $174.9M an increase of 1.3% Y/Y, with orders of $151.12M (-0.2% Y/Y).</li><li>Sales by business units: Commercial $39.65M (-13.9% Y/Y); Live Events $59.32M (+7.7% Y/Y); High School Park and Recreation $30.19M (-4.4% Y/Y); Transportation $20.33M (+12.5% Y/Y); and International $25.42M (+16.2% Y/Y).</li><li>Q2 Gross margin <font color=\"red\">declined by 184 bps </font>to 22.9%; and operating margin<font color=\"red\"> declined by 246 bps</font> to 2.8%.</li><li>Net cash used in operating activities YTD was $10.27M, compared to cash provided $22.56M a year ago. Free cash flow was negative $19.89M.</li><li>Product order backlog was at $182M, compared to $150M a year earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3522341-daktronics-eps-line-misses-revenue\" target=\"_blank\">Daktronics EPS in-line, misses on revenue</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3522417\" data-linked=\"Daktronics slides 9% post Q2 results\" data-tweet=\"$DAKT - Daktronics slides 9% post Q2 results https://seekingalpha.com/news/3522417-daktronics-slides-9-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3522417-daktronics-slides-9-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522415\" data-ts=\"1574867265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGCO\" target=\"_blank\">AGCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522415-deere-outlook-weighs-on-farm-equipment-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere outlook weighs on farm equipment stocks</a></h4><ul><li>Farm machinery stocks open lower in early trade after Deere <a href=\"https://seekingalpha.com/news/3522338-deere-minus-4_5-percent-2020-profit-warning\" target=\"_blank\">warned</a> on 2020 profits amid \"lingering trade tensions.\"</li><li>AGCO (<a href='https://seekingalpha.com/symbol/AGCO' title='AGCO Corporation'>AGCO</a> <font color=\"red\">-1.8%</font>); CNH Industrial <a href='https://seekingalpha.com/symbol/CNHI' title='CNH Industrial N.V.'>CNHI</a> <font color=\"red\">-2.8%</font>; Lindsay (<a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a> <font color=\"red\">-0.3%</font>); Alamo (<a href='https://seekingalpha.com/symbol/ALG' title='Alamo Group Inc.'>ALG</a> <font color=\"red\">-0.3%)</font>; Briggs &amp; Stratton (<a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a> <font color=\"red\">-0.3%</font>); Titan International (<a href='https://seekingalpha.com/symbol/TWI' title='Titan International, Inc.'>TWI</a> <font color=\"red\">-0.3%</font>).</li><li>The sentiment is also weighing slightly on construction equipment shares: Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color=\"red\">-0.7%</font>); Terex (<a href='https://seekingalpha.com/symbol/TEX' title='Terex Corporation'>TEX</a> <font color=\"red\">-0.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3522415\" data-linked=\"Deere outlook weighs on farm equipment stocks\" data-tweet=\"$AGCO $CNHI $LNN - Deere outlook weighs on farm equipment stocks https://seekingalpha.com/news/3522415-deere-outlook-weighs-on-farm-equipment-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3522415-deere-outlook-weighs-on-farm-equipment-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522409\" data-ts=\"1574866485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522409-legal-loss-sends-irobot-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Legal loss sends iRobot lower</a></h4><ul> <li>Shares of iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) are <font color=\"red\">down 3.35%</font> after the company <a href=\"https://www.bloomberg.com/news/articles/2019-11-26/irobot-loses-bid-to-block-sales-of-sharkninja-vacuums\" target=\"_blank\">loses</a> a court challenge against a Roomba knockoff.</li> <li>While the company says it will continue with its patent defense, the cheaper SharkNinja product will be available to consumers during the holiday season.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3522409\" data-linked=\"Legal loss sends iRobot lower\" data-tweet=\"$IRBT - Legal loss sends iRobot lower https://seekingalpha.com/news/3522409-legal-loss-sends-irobot-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3522409-legal-loss-sends-irobot-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522405\" data-ts=\"1574865842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MANU\" target=\"_blank\">MANU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522405-manchester-united-jumps-peer-manchester-city-sells-500m-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manchester United jumps as peer Manchester City sells $500M stake</a></h4><ul><li>Manchester United (<a href='https://seekingalpha.com/symbol/MANU' title='Manchester United plc'>MANU</a> <font color='green'>+9.8%</font>) surges in early trade after English Premier League peer Manchester City <a href=\"https://uk.reuters.com/article/uk-soccer-england-mci-silver-lake-deals/manchester-city-owner-scores-4-8-billion-price-tag-with-stake-sale-idUKKBN1Y10FH\" target=\"_blank\">agreed to sell a $500M stake</a> to the Silver  Lake P-E firm, valuing the soccer team at $4.8B (£3.7B).</li><li>Silver Lake is buying slightly more than 10% of City Football Group, which  owns reigning EPL champions Manchester City and teams  in the U.S., Australia and China.</li><li>Manchester United, Man City's top domestic rival, is majority owned by the American Glazer family and are valued at $2.8B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522405\" data-linked=\"Manchester United jumps as peer Manchester City sells $500M stake\" data-tweet=\"$MANU - Manchester United jumps as peer Manchester City sells $500M stake https://seekingalpha.com/news/3522405-manchester-united-jumps-peer-manchester-city-sells-500m-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3522405-manchester-united-jumps-peer-manchester-city-sells-500m-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522385\" data-ts=\"1574864454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522385-irishman-seen-delivering-for-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Irishman seen delivering for Netflix</a></h4><ul> <li>JPMorgan is constructive on Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) as the streamer moves past the anxiety around the Disney+ launch and generates buzz ahead of the streaming debut of <em>The Irishman</em> and other Q4 titles.</li> <li>\"We like Netflix shares at current levels, and after a stretch of tougher data points (i.e., DIS+ initial 10M subs), we believe the momentum could start to turn more positive with release of The Irishman on NFLX just hours away, representing NFLX\u2019s biggest-ever film investment,\" writes analyst Doug Anmuth.</li> <li>\"Looking forward, key catalysts include NFLX-provided intra-quarter viewing metrics for its higher profile upcoming content releases, NFLX filing its historical new reporting metrics of revenue and subs by region ahead of 4Q earnings, and DIS 1QFY20 earnings with an updated quarter-ending DIS+ sub number. Importantly, we believe more streaming options will ultimately accelerate the shift away from linear TV, benefitting NFLX.\"</li> <li>The firm keeps an Overweight rating on NFLX and price target of $425 (based on a sum-of-the-parts valuation of a 17.5X multiple on 2021 U.S. streaming EBITDA of $3.4B, 10X multiple on 2020 international streaming revenue of $14.5B and 7X multiple on 2021 U.S. DVD EBITDA of $98M).</li> <li>NFLX <font color=\"green\">+0.33%</font> premarket to $313.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522385\" data-linked=\"The Irishman seen delivering for Netflix\" data-tweet=\"$NFLX - The Irishman seen delivering for Netflix https://seekingalpha.com/news/3522385-irishman-seen-delivering-for-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3522385-irishman-seen-delivering-for-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522380\" data-ts=\"1574864036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522380-navx-tnxp-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NAVX, TNXP among premarket gainers</a></h4><ul><li>Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+50%</font> after <a href=\"https://seekingalpha.com/news/3522286-safe-t-group-reports-q3-results\" target=\"_blank\">Q3 results</a>.</li><li>AVX (NYSE:<a href='https://seekingalpha.com/symbol/AVX' title='AVX Corporation'>AVX</a>) <font color=\"green\">+35%</font> as Kyocera offers to <a href=\"https://seekingalpha.com/news/3522360-kyocera-offers-buy-remaining-avx-shares-19_50\" target=\"_blank\">buy</a> remaining AVX shares for $19.50 each.</li><li>Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+30%</font> after <a href=\"https://seekingalpha.com/news/3522207-fuwei-films-reports-q3-results\" target=\"_blank\">Q3 results</a>.</li><li>AMERI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRH' title='AMERI Holdings, Inc.'>AMRH</a>) <font color=\"green\">+15%</font> as Ameri100 <a href=\"https://seekingalpha.com/pr/17712467-ameri100-awarded-approximately-1-million-s-4hana-implementation-contract\" target=\"_blank\">awarded</a> ~$1M S/4HANA implementation contract.</li><li>Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/news/3522243-tonix-gets-minutes-fdas-tonmya-guidance-meeting\" target=\"_blank\">receiving</a> the FDA Tonmya guidance meeting.</li><li>My Size (NASDAQ:<a href='https://seekingalpha.com/symbol/MYSZ' title='My Size, Inc.'>MYSZ</a>) <font color=\"green\">+13%</font> on <a href=\"https://seekingalpha.com/pr/17712557-size-secures-commercial-contract-mysizeid-turkish-apparel-company-ay-marka-mag-azacilik-s\" target=\"_blank\">securing</a> commercial contract for MySizeID with Turkish apparel company AY Marka Mağazacılık A.Ş.</li><li>Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+8%</font> after <a href=\"https://seekingalpha.com/news/3522289-uxin-reports-q3-results\" target=\"_blank\">Q3 results</a>.</li><li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) <font color=\"green\">+7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522380\" data-linked=\"NAVX, TNXP among premarket gainers\" data-tweet=\"$SFET $AVX $FFHL - NAVX, TNXP among premarket gainers https://seekingalpha.com/news/3522380-navx-tnxp-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522380-navx-tnxp-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522378\" data-ts=\"1574863643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522378-arav-ges-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARAV, GES among premarket losers</a></h4><ul><li>Aravive (NASDAQ:<a href='https://seekingalpha.com/symbol/ARAV' title='Aravive, Inc.'>ARAV</a>) <font color=\"red\">-19%</font> on <a href=\"https://seekingalpha.com/news/3522375-aravive-20-percent-premarket-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Guess' (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess&#39;, Inc.'>GES</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3522223-guess-eps-beats-0_04-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522378\" data-linked=\"ARAV, GES among premarket losers\" data-tweet=\"$ARAV $GES - ARAV, GES among premarket losers https://seekingalpha.com/news/3522378-arav-ges-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522378-arav-ges-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522375\" data-ts=\"1574863023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARAV\" target=\"_blank\">ARAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522375-aravive-down-20-premarket-on-pricing-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aravive down 20% premarket on pricing equity offering</a></h4><ul> <li>Aravive (NASDAQ:<a href='https://seekingalpha.com/symbol/ARAV' title='Aravive, Inc.'>ARAV</a>) has <a href=\"https://seekingalpha.com/pr/17712558-aravive-announces-pricing-public-offering-common-stock\" target=\"_blank\">priced</a> its public offering of 3,333,334 common shares at $7.50 per share, for expected gross proceeds of ~$25M.</li>   <li>Underwriters' over-allotment is an additional 500,000 shares.</li>  <li>Net proceeds will be used for research, development and manufacturing of product candidates, and for other general corporate purposes.</li><li>Closing date is December 2.</li><li>Shares are down <font color=\"red\">20%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3522272-aravive-minus-12_8-percent-proposed-equity-offering\" target=\"_blank\">Aravive -12.8% on proposed equity offering</a> (Nov. 26)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3522375\" data-linked=\"Aravive down 20% premarket on pricing equity offering\" data-tweet=\"$ARAV - Aravive down 20% premarket on pricing equity offering https://seekingalpha.com/news/3522375-aravive-down-20-premarket-on-pricing-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3522375-aravive-down-20-premarket-on-pricing-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522374\" data-ts=\"1574862804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL\" target=\"_blank\">DELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522374-dell-analysts-cautious-after-sales-forecast-trim\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dell analysts cautious after sales forecast trim</a></h4><ul><li>Deutsche Bank cuts its Dell (NYSE:<a href='https://seekingalpha.com/symbol/DELL' title='Dell Technologies Inc.'>DELL</a>) target by $2 to $60, citing concerns with Intel's CPU constraints and the impact on Dell's business.</li><li>The bank maintains a Buy rating, believing Dell has a \"number of under-appreciated offsets (market share gain vs. peers, valuation downside protection, deleverage potential).\"</li><li>Citi analyst Jim Suva maintains a Buy rating and $65 target but came away from yesterday's <a href=\"https://seekingalpha.com/news/3522273-dell-minus-5-percent-trims-full-year-sales-forecast\" target=\"_blank\">earnings report</a> surprised that Dell reduced its FY20 sales guidance after only two months.</li><li>Suva expects Dell to hit investment grade metrics after FY21.</li><li>Dell shares are <font color=\"red\">down 4.2%</font> pre-market to $50.95.</li><li>DELL has a Bullish average <a href=\"https://seekingalpha.com/symbol/DELL/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522374\" data-linked=\"Dell analysts cautious after sales forecast trim\" data-tweet=\"$DELL - Dell analysts cautious after sales forecast trim https://seekingalpha.com/news/3522374-dell-analysts-cautious-after-sales-forecast-trim?source=tweet\" data-url=\"https://seekingalpha.com/news/3522374-dell-analysts-cautious-after-sales-forecast-trim\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522366\" data-ts=\"1574861450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522366-canaccord-lifts-box-target-stays-on-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord lifts Box target, stays on sidelines</a></h4><ul><li>Canaccord Genuity lifts its Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box, Inc.'>BOX</a>) target from $16 to $18 after yesterday's <a href=\"https://seekingalpha.com/news/3522252-box-plus-1_3-percent-beat-raise\" target=\"_blank\">earnings report</a>, saying BOX \"intends to grow its way out of an excessive cost structure.\"</li><li>The firm says Box needs to improve execution \"before the stock will sustainably work.\"</li><li>Canaccord maintains a Hold rating on Box. The company has a Neutral average <a href=\"https://seekingalpha.com/symbol/BOX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Box shares are <font color=\"green\">up 3.7%</font> pre-market to $17.31.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522366\" data-linked=\"Canaccord lifts Box target, stays on sidelines\" data-tweet=\"$BOX - Canaccord lifts Box target, stays on sidelines https://seekingalpha.com/news/3522366-canaccord-lifts-box-target-stays-on-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3522366-canaccord-lifts-box-target-stays-on-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522361\" data-ts=\"1574860812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522361-dicks-sporting-goods-takes-victory-lap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s Sporting Goods takes a victory lap</a></h4><ul> <li>Analysts are busy resetting expectations on Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='DICK&#39;S Sporting Goods, Inc.'>DKS</a>) after the retailer knocked it out of the park with its <a href=\"https://seekingalpha.com/news/3522050-dicks-plus-13-percent-earnings-smasher\" target=\"_blank\">Q3 earnings report</a>.</li> <li>Evercore ISIS lifts Dick's to an Outperform rating and assigns a price target of $60.</li> <li>Barclays moves to a Overweight rating and sets a price target of $56.</li> <li>Baird pushes its price target on Dick's all the way to $51 from $36.</li> <li>The analyst love follows Dick's recording its strongest same-store sales growth mark since 2013. The confidence in Dick's is based partially on strong execution by management, but also on the thinned-out playing field of sporting goods chains.</li>  <li>Shares of Dick's are <font color=\"green\">up 1.26%</font> premarket to follow on yesterday's 18.6% pop.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522361\" data-linked=\"Dick&#39;s Sporting Goods takes a victory lap\" data-tweet=\"$DKS - Dick&#39;s Sporting Goods takes a victory lap https://seekingalpha.com/news/3522361-dicks-sporting-goods-takes-victory-lap?source=tweet\" data-url=\"https://seekingalpha.com/news/3522361-dicks-sporting-goods-takes-victory-lap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522360\" data-ts=\"1574860466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVX\" target=\"_blank\">AVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522360-kyocera-offers-to-buy-remaining-avx-shares-for-19_50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kyocera offers to buy remaining AVX shares for $19.50 each</a></h4><ul><li>AVX Corp. (NYSE:<a href='https://seekingalpha.com/symbol/AVX' title='AVX Corporation'>AVX</a>) <font color=\"green\">+35.7%</font> pre-market after Kyocera (<a href='https://seekingalpha.com/symbol/KYOCF' title='Kyocera Corporation'>OTCPK:KYOCF</a>) announces a <a href=\"https://www.sec.gov/Archives/edgar/data/859163/000143774919023601/ex_165829.htm\" target=\"_blank\">proposal to acquire</a> the 28% of the company's outstanding shares it does not already own for $19.50/share in cash.</li><li>The offer represents a 29.7% premium over yesterday's AVX closing price.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522360\" data-linked=\"Kyocera offers to buy remaining AVX shares for $19.50 each\" data-tweet=\"$AVX $KYOCF $KYOCY - Kyocera offers to buy remaining AVX shares for $19.50 each https://seekingalpha.com/news/3522360-kyocera-offers-to-buy-remaining-avx-shares-for-19_50?source=tweet\" data-url=\"https://seekingalpha.com/news/3522360-kyocera-offers-to-buy-remaining-avx-shares-for-19_50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522345\" data-ts=\"1574858625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTI\" target=\"_blank\">BTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522345-british-american-tobaccoplus-2-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">British American Tobacco +2% after guidance update</a></h4><ul> <li>British American Tobacco (NYSE:<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c.'>BTI</a>) says it expects a <a href=\"https://www.theguardian.com/business/2019/nov/27/us-vaping-backlash-dents-british-american-tobacco-revenues\" target=\"_blank\">slowdown</a> in the U.S. vaping market will lead to lower revenue growth in its vaping arm than it originally anticipated.</li> <li>The company forecasts vaping revenue will fall on the low end of its previously-announced range of 30% to 50% growth in FY19.</li><li>On the positive side, BAT says total revenue is expected to grow in the upper half of its 3% to 5% forecasted range for the long term as the tobacco company benefits from stronger pricing and market share gains in  the traditional cigarettes business. BAT also maintained its forecast for EPS growth in the high-single-digit range.</li> <li>Shares of British American Tobacco are <font color=\"green\">up 2.42%</font> in London trading.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3522345\" data-linked=\"British American Tobacco +2% after guidance update\" data-tweet=\"$BTI - British American Tobacco +2% after guidance update https://seekingalpha.com/news/3522345-british-american-tobaccoplus-2-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3522345-british-american-tobaccoplus-2-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522342\" data-ts=\"1574858021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522342-vmware-targets-raised-after-q3-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VMware targets raised after Q3 beats</a></h4><ul><li>KeyBanc maintains an Overweight rating on VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) and raises the target from $175 to $182 after yesterday's <a href=\"https://seekingalpha.com/news/3522244-vmware-reports-q3-beats-licensing-strength\" target=\"_blank\">Q3 beats</a>.</li><li>The bank calls the results \"stable\" despite concerns the company was seeing weakening U.S. and international demand.</li><li>KeyBanc: \"We remain buyers of VMW as core growth platforms continued to demonstrate solid results.\"</li><li>More action: Citi (Buy) increases its target from $183 to $198, citing \"strong performance across products and geos.\"</li><li>VMW shares are <font color=\"green\">up 2.2%</font> pre-market to $168.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522342\" data-linked=\"VMware targets raised after Q3 beats\" data-tweet=\"$VMW - VMware targets raised after Q3 beats https://seekingalpha.com/news/3522342-vmware-targets-raised-after-q3-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3522342-vmware-targets-raised-after-q3-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522339\" data-ts=\"1574857858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522339-protalix-bio-to-host-kol-meeting-on-prx-102-shares-up-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix Bio to host KOL meeting on PRX\u2011102; shares up 8% premarket</a></h4><ul><li>Protalix BioTherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc.'>PLX</a>) will <a href=\"https://seekingalpha.com/pr/17712359-protalix-biotherapeutics-hosting-key-opinion-leader-meeting-prx-102-drug-candidate-treatment\" target=\"_blank\">host</a> a key opinion leader &#40;KOL&#41; meeting on pegunigalsidase alfa, or PRX\u2011102, for the treatment of Fabry Disease, in New York City on December 2, at 8:00 a.m. EST.</li>  <li>The meeting will feature a presentation from KOL David G. Warnock, M.D., who will discuss the current treatment landscape, as well as the unmet medical need for treating Fabry patients.</li> <li>The Company will also provide an update on PRX\u2011102.</li><li>Shares are up <font color=\"green\">8%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522339\" data-linked=\"Protalix Bio to host KOL meeting on PRX\u2011102; shares up 8% premarket\" data-tweet=\"$PLX - Protalix Bio to host KOL meeting on PRX\u2011102; shares up 8% premarket https://seekingalpha.com/news/3522339-protalix-bio-to-host-kol-meeting-on-prx-102-shares-up-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3522339-protalix-bio-to-host-kol-meeting-on-prx-102-shares-up-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522338\" data-ts=\"1574857544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522338-deereminus-4_5-after-2020-profit-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere -4.5% after 2020 profit warning</a></h4><ul><li>Net income of $681M in the fiscal fourth quarter, or $2.14 per share, compared with $748M, or $2.30 per share a year ago.</li><li>Worldwide net sales increased 5% Y/Y to $9.896B. Segment Sales: Equipment +4%; Agriculture &amp; Turf. +3%; Construction &amp; Forestry +8%.</li><li>\"Lingering trade tensions coupled with a year of difficult growing and harvesting conditions have caused many farmers to become cautious about making major investments in new equipment,\" CEO John May declared.</li><li>Lowered outlook yet again: Net income for fiscal 2020 is forecast to be in a range of $2.7B-$3.1B (from a previous $3.2B). Global sales of agriculture and turf equipment are forecast to fall 5% to 10%, and construction and forestry equipment sales are anticipated to slide 10% to 15%.</li><li><a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color=\"red\">-4.5%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3522318-deere-eps-line-beats-revenue\" target=\"_blank\">FQ4 results</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3522338\" data-linked=\"Deere -4.5% after 2020 profit warning\" data-tweet=\"$DE - Deere -4.5% after 2020 profit warning https://seekingalpha.com/news/3522338-deereminus-4_5-after-2020-profit-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3522338-deereminus-4_5-after-2020-profit-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522335\" data-ts=\"1574857176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYS\" target=\"_blank\">KEYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522335-keys-remains-citis-top-pick-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KEYS remains Citi&#39;s &#39;top pick&#39; after earnings</a></h4><ul><li>Citi raises its Keysight Technologies (NYSE:<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies, Inc.'>KEYS</a>) target by $10 to $125 after yesterday's <a href=\"https://seekingalpha.com/news/3522254-keysight-plus-1_8-percent-beats-line-view\" target=\"_blank\">Q4 beats</a>.</li><li>The firm says that KEYS \"remains our top stock for 2019\" after the better-than-expected results.</li><li>Analyst Jim Suva calls KEYS \"an agnostic way to invest in 5G\" that doesn't require the investor to pick which OEM vendor or product will gain share.</li><li>Citi maintains a Buy rating on Keysight. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/KEYS?s=keys\" target=\"_blank\">Sell Side rating</a>.</li><li>KEYS shares are <font color=\"green\">up 2.3%</font> pre-market to $108.17.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522335\" data-linked=\"KEYS remains Citi&#39;s &#39;top pick&#39; after earnings\" data-tweet=\"$KEYS - KEYS remains Citi&#39;s &#39;top pick&#39; after earnings https://seekingalpha.com/news/3522335-keys-remains-citis-top-pick-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3522335-keys-remains-citis-top-pick-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522332\" data-ts=\"1574856807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522332-under-armourplus-3-after-raymond-james-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour +3% after Raymond James nod</a></h4><ul> <li>Raymond James hikes Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>, <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc.'>UA</a>) to a Strong Buy rating.</li> <li>The investment firm assigns a price target of $30 to UA to rep huge upside potential and easily top the average sell-side PT of $20.64.</li> <li>Shares of Under Armour are <font color=\"green\">up 2.89%</font> premarket to $18.51 vs. the 52-week trading range of $16.52 to $27.72.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522332\" data-linked=\"Under Armour +3% after Raymond James nod\" data-tweet=\"$UAA $UA - Under Armour +3% after Raymond James nod https://seekingalpha.com/news/3522332-under-armourplus-3-after-raymond-james-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3522332-under-armourplus-3-after-raymond-james-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522329\" data-ts=\"1574856389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMWYY\" target=\"_blank\">BMWYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522329-bmw-gains-after-reaching-labor-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMW gains after reaching labor deal</a></h4><ul> <li>BMW (<a href='https://seekingalpha.com/symbol/BMWYY' title='Bayerische Motoren Werke Aktiengesellschaft'>OTCPK:BMWYY</a>) struck a delicate <a href=\"https://www.reuters.com/article/us-bmw-restructuring/bmw-management-and-labor-reach-agreement-to-cut-costs-idUSKBN1Y1192\" target=\"_blank\">deal</a> with a union representing employees.</li> <li>The German automaker avoided taking \"drastic measures\" with labor costs, while staying on track to achieve cost savings of more than \u20ac12B by 2022.</li> <li>BMW's labor deal follows <a href=\"https://seekingalpha.com/news/3522020-audi-trims-workforce\" target=\"_blank\">news</a> from yesterday that Audi will cut 9.5K jobs over the next several years to boost profit.</li> <li>Shares of BMW are <font color=\"green\">up 1.15%</font> in Frankfurt trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522329\" data-linked=\"BMW gains after reaching labor deal\" data-tweet=\"$BMWYY - BMW gains after reaching labor deal https://seekingalpha.com/news/3522329-bmw-gains-after-reaching-labor-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3522329-bmw-gains-after-reaching-labor-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522296\" data-ts=\"1574847277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522296-shares-of-alibaba-advance-for-second-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Alibaba advance for second day</a></h4><ul><li>\"Investors are jumping all over it in Hong Kong,\" James Gerrish, portfolio manager at Shaw and Partners, <a href=\"https://www.cnbc.com/2019/11/27/alibaba-surges-for-second-day-after-blockbuster-debut-in-hong-kong.html\" target=\"_blank\">told</a> CNBC's <i>Capital Connection</i>.</li><li>Following a blockbuster listing in the city on Tuesday, Alibaba's (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) Hong Kong-listed shares <font color=\"green\">rose another 3%</font> overnight - bringing its first two days of <font color=\"green\">gains to nearly 10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522296\" data-linked=\"Shares of Alibaba advance for second day\" data-tweet=\"$BABA - Shares of Alibaba advance for second day https://seekingalpha.com/news/3522296-shares-of-alibaba-advance-for-second-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3522296-shares-of-alibaba-advance-for-second-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":47,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}